Reviews Carmustine


No reviews yet.

BiCNU Drug Description
BiCNU
(carmustine) For Injection


WARNINGS

BiCNU (carmustine for injection) should be administered under the supervision
of a qualified physician experienced in the use of cancer chemotherapeutic agents.

Bone marrow suppression, notably thrombocytopenia and leukopenia, which may
contribute to bleeding and overwhelming infections in an already compromised
patient, is the most common and severe of the toxic effects of BiCNU (see WARNINGS
and ADVERSE REACTIONS).
Since the major toxicity is delayed bone marrow suppression, blood counts should
be monitored weekly for at least 6 weeks after a dose (see ADVERSE REACTIONS).
At the recommended dosage, courses of BiCNU should not be given more frequently
than every 6 weeks.
The bone marrow toxicity of BiCNU is cumulative and therefore dosage adjustment
must be considered on the basis of nadir blood counts from prior dose (see “Dosage
Adjustment Table” under DOSAGE AND ADMINISTRATION).
Pulmonary toxicity from BiCNU appears to be dose related. Patients receiving
greater than 1400 mg/m² cumulative dose are at significantly higher risk
than those receiving less.
Delayed pulmonary toxicity can occur years after treatment, and can result
in death, particularly in patients treated in childhood (see ADVERSE
REACTIONS and PRECAUTIONS: Pediatric
Use).

DRUG DESCRIPTION



What are the possible side effects of carmustine (BiCNU, Gliadel)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat or signs of infection);
seizures, brain...
Read All Potential Side Effects for BiCNU »




BiCNU® (carmustine for injection) is one of the nitrosoureas used in the
treatment of certain neoplastic diseases. It is 1,3-bis (2-chloroethyl)-1-nitrosourea.
It is sterile lyophilized pale yellow flakes or congealed mass with a molecular
weight of 214.06. It is highly soluble in alcohol and lipids, and poorly soluble
in water. BiCNU is administered by intravenous infusion after reconstitution
as recommended.










BiCNU is available in 100 mg single dose vials of lyophilized material. Sterile
diluent for constitution of BiCNU is co-packaged with the active drug product
for use in constitution of the lyophile. The diluent is supplied in an ampule
containing 3 mL of Dehydrated Alcohol Injection, USP.Last reviewed on RxList: 9/13/2007




BiCNU Drug Description
BiCNU
(carmustine) For Injection


WARNINGS

BiCNU (carmustine for injection) should be administered under the supervision
of a qualified physician experienced in the use of cancer chemotherapeutic agents.

Bone marrow suppression, notably thrombocytopenia and leukopenia, which may
contribute to bleeding and overwhelming infections in an already compromised
patient, is the most common and severe of the toxic effects of BiCNU (see WARNINGS
and ADVERSE REACTIONS).
Since the major toxicity is delayed bone marrow suppression, blood counts should
be monitored weekly for at least 6 weeks after a dose (see ADVERSE REACTIONS).
At the recommended dosage, courses of BiCNU should not be given more frequently
than every 6 weeks.
The bone marrow toxicity of BiCNU is cumulative and therefore dosage adjustment
must be considered on the basis of nadir blood counts from prior dose (see “Dosage
Adjustment Table” under DOSAGE AND ADMINISTRATION).
Pulmonary toxicity from BiCNU appears to be dose related. Patients receiving
greater than 1400 mg/m² cumulative dose are at significantly higher risk
than those receiving less.
Delayed pulmonary toxicity can occur years after treatment, and can result
in death, particularly in patients treated in childhood (see ADVERSE
REACTIONS and PRECAUTIONS: Pediatric
Use).

DRUG DESCRIPTION



What are the possible side effects of carmustine (BiCNU, Gliadel)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat or signs of infection);
seizures, brain...
Read All Potential Side Effects for BiCNU »




BiCNU® (carmustine for injection) is one of the nitrosoureas used in the
treatment of certain neoplastic diseases. It is 1,3-bis (2-chloroethyl)-1-nitrosourea.
It is sterile lyophilized pale yellow flakes or congealed mass with a molecular
weight of 214.06. It is highly soluble in alcohol and lipids, and poorly soluble
in water. BiCNU is administered by intravenous infusion after reconstitution
as recommended.










BiCNU is available in 100 mg single dose vials of lyophilized material. Sterile
diluent for constitution of BiCNU is co-packaged with the active drug product
for use in constitution of the lyophile. The diluent is supplied in an ampule
containing 3 mL of Dehydrated Alcohol Injection, USP.Last reviewed on RxList: 9/13/2007




BiCNU Drug Description
BiCNU
(carmustine) For Injection


WARNINGS

BiCNU (carmustine for injection) should be administered under the supervision
of a qualified physician experienced in the use of cancer chemotherapeutic agents.

Bone marrow suppression, notably thrombocytopenia and leukopenia, which may
contribute to bleeding and overwhelming infections in an already compromised
patient, is the most common and severe of the toxic effects of BiCNU (see WARNINGS
and ADVERSE REACTIONS).
Since the major toxicity is delayed bone marrow suppression, blood counts should
be monitored weekly for at least 6 weeks after a dose (see ADVERSE REACTIONS).
At the recommended dosage, courses of BiCNU should not be given more frequently
than every 6 weeks.
The bone marrow toxicity of BiCNU is cumulative and therefore dosage adjustment
must be considered on the basis of nadir blood counts from prior dose (see “Dosage
Adjustment Table” under DOSAGE AND ADMINISTRATION).
Pulmonary toxicity from BiCNU appears to be dose related. Patients receiving
greater than 1400 mg/m² cumulative dose are at significantly higher risk
than those receiving less.
Delayed pulmonary toxicity can occur years after treatment, and can result
in death, particularly in patients treated in childhood (see ADVERSE
REACTIONS and PRECAUTIONS: Pediatric
Use).

DRUG DESCRIPTION



What are the possible side effects of carmustine (BiCNU, Gliadel)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat or signs of infection);
seizures, brain...
Read All Potential Side Effects for BiCNU »




BiCNU® (carmustine for injection) is one of the nitrosoureas used in the
treatment of certain neoplastic diseases. It is 1,3-bis (2-chloroethyl)-1-nitrosourea.
It is sterile lyophilized pale yellow flakes or congealed mass with a molecular
weight of 214.06. It is highly soluble in alcohol and lipids, and poorly soluble
in water. BiCNU is administered by intravenous infusion after reconstitution
as recommended.










BiCNU is available in 100 mg single dose vials of lyophilized material. Sterile
diluent for constitution of BiCNU is co-packaged with the active drug product
for use in constitution of the lyophile. The diluent is supplied in an ampule
containing 3 mL of Dehydrated Alcohol Injection, USP.Last reviewed on RxList: 9/13/2007




BiCNU Drug Description
BiCNU
(carmustine) For Injection


WARNINGS

BiCNU (carmustine for injection) should be administered under the supervision
of a qualified physician experienced in the use of cancer chemotherapeutic agents.

Bone marrow suppression, notably thrombocytopenia and leukopenia, which may
contribute to bleeding and overwhelming infections in an already compromised
patient, is the most common and severe of the toxic effects of BiCNU (see WARNINGS
and ADVERSE REACTIONS).
Since the major toxicity is delayed bone marrow suppression, blood counts should
be monitored weekly for at least 6 weeks after a dose (see ADVERSE REACTIONS).
At the recommended dosage, courses of BiCNU should not be given more frequently
than every 6 weeks.
The bone marrow toxicity of BiCNU is cumulative and therefore dosage adjustment
must be considered on the basis of nadir blood counts from prior dose (see “Dosage
Adjustment Table” under DOSAGE AND ADMINISTRATION).
Pulmonary toxicity from BiCNU appears to be dose related. Patients receiving
greater than 1400 mg/m² cumulative dose are at significantly higher risk
than those receiving less.
Delayed pulmonary toxicity can occur years after treatment, and can result
in death, particularly in patients treated in childhood (see ADVERSE
REACTIONS and PRECAUTIONS: Pediatric
Use).

DRUG DESCRIPTION



What are the possible side effects of carmustine (BiCNU, Gliadel)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat or signs of infection);
seizures, brain...
Read All Potential Side Effects for BiCNU »




BiCNU® (carmustine for injection) is one of the nitrosoureas used in the
treatment of certain neoplastic diseases. It is 1,3-bis (2-chloroethyl)-1-nitrosourea.
It is sterile lyophilized pale yellow flakes or congealed mass with a molecular
weight of 214.06. It is highly soluble in alcohol and lipids, and poorly soluble
in water. BiCNU is administered by intravenous infusion after reconstitution
as recommended.










BiCNU is available in 100 mg single dose vials of lyophilized material. Sterile
diluent for constitution of BiCNU is co-packaged with the active drug product
for use in constitution of the lyophile. The diluent is supplied in an ampule
containing 3 mL of Dehydrated Alcohol Injection, USP.Last reviewed on RxList: 9/13/2007




BiCNU Drug Description
BiCNU
(carmustine) For Injection


WARNINGS

BiCNU (carmustine for injection) should be administered under the supervision
of a qualified physician experienced in the use of cancer chemotherapeutic agents.

Bone marrow suppression, notably thrombocytopenia and leukopenia, which may
contribute to bleeding and overwhelming infections in an already compromised
patient, is the most common and severe of the toxic effects of BiCNU (see WARNINGS
and ADVERSE REACTIONS).
Since the major toxicity is delayed bone marrow suppression, blood counts should
be monitored weekly for at least 6 weeks after a dose (see ADVERSE REACTIONS).
At the recommended dosage, courses of BiCNU should not be given more frequently
than every 6 weeks.
The bone marrow toxicity of BiCNU is cumulative and therefore dosage adjustment
must be considered on the basis of nadir blood counts from prior dose (see “Dosage
Adjustment Table” under DOSAGE AND ADMINISTRATION).
Pulmonary toxicity from BiCNU appears to be dose related. Patients receiving
greater than 1400 mg/m² cumulative dose are at significantly higher risk
than those receiving less.
Delayed pulmonary toxicity can occur years after treatment, and can result
in death, particularly in patients treated in childhood (see ADVERSE
REACTIONS and PRECAUTIONS: Pediatric
Use).

DRUG DESCRIPTION



What are the possible side effects of carmustine (BiCNU, Gliadel)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat or signs of infection);
seizures, brain...
Read All Potential Side Effects for BiCNU »




BiCNU® (carmustine for injection) is one of the nitrosoureas used in the
treatment of certain neoplastic diseases. It is 1,3-bis (2-chloroethyl)-1-nitrosourea.
It is sterile lyophilized pale yellow flakes or congealed mass with a molecular
weight of 214.06. It is highly soluble in alcohol and lipids, and poorly soluble
in water. BiCNU is administered by intravenous infusion after reconstitution
as recommended.










BiCNU is available in 100 mg single dose vials of lyophilized material. Sterile
diluent for constitution of BiCNU is co-packaged with the active drug product
for use in constitution of the lyophile. The diluent is supplied in an ampule
containing 3 mL of Dehydrated Alcohol Injection, USP.Last reviewed on RxList: 9/13/2007





Other reviews about Carmustine on wordpress

Chemotherapy can be more toxic to brain cells than to cancer cells
  by pjwalker911
EurekNet | Nov 29, 2006 Drugs used to treat cancer may damage normal, healthy brain cells more than the cancer cells they are meant to target. A study published […]


CHEMO 'KILLS BRAIN CELLS'
  by pjwalker911
Mirror | Nov 30, 2006 DRUGS used to fight cancer could have a harmful effect on the brain, according to a new study. The common chemotherapy treatments can kill […]


Pharmaceutical, Biotechnology, and Croaker Fuse Conciliarism Webcast
  by kyleeuridicempd
MGI PHARMA so that Contribute at the 2007 Merrill Annihilate Cosmic Pharmaceutical, Biotechnology and Chiropractic AM-FM receiver Huddle MINNEAPOLIS--(Bounden duty Cord)--MGI PHARMA, INC. […]


Pharmaceutical, Biotechnology, and Croaker Fuse Conciliarism Webcast
  by kyleeuridicempd
MGI PHARMA so that Contribute at the 2007 Merrill Annihilate Cosmic Pharmaceutical, Biotechnology and Chiropractic AM-FM receiver Huddle MINNEAPOLIS--(Bounden duty Cord)--MGI PHARMA, INC. […]


Pharmaceutical, Biotechnology, and Neurological Signet Round table Webcast
  by uxxsachistephen
MGI PHARMA upon Give words to at the 2007 Merrill Purge Unconditioned Pharmaceutical, Biotechnology and Hydropathic Scurvy trick Powwow MINNEAPOLIS--(Syndicate Electric cable)--MGI PHARMA, […]


Pharmaceutical, Biotechnology, and Neurological Signet Round table Webcast
  by uxxsachistephen
MGI PHARMA upon Give words to at the 2007 Merrill Purge Unconditioned Pharmaceutical, Biotechnology and Hydropathic Scurvy trick Powwow MINNEAPOLIS--(Syndicate Electric cable)--MGI PHARMA, […]


Testing, Testing
  by Mike Hamel
I窶况e had seven medical tests in the last two days and I was conscious for all of them, meaning they weren窶冲 too stressful. On Monday I have a […]


Weekly Menu
  by jphilg
For years, I've participated on a cooking bulletin board, and for a long time I posted my weekly menu plan on a thread with lots of other weekly […]


First and second day...
  by kidbuckeye
I arrived here and was admitted without any real problems. ツYesterday I had Carmustine also known as BiCNU. It was interesting, made me feel really strange for a […]


Day -6
  by leemanfor
I had carmustine last night and tolerated it really well. I only had a slight headache that went away later on in the evening, and no nausea. Today […]



Other reviews about Carmustine on web:

Carmustine or BCNU (= "bis-chloronitrosourea") is a mustard gas-related テδ偲つア-chloro-nitrosourea compound used as an alkylating agent in chemotherapy. Carmustine - Wikipedia, the free encyclopedia


Carmustine is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. This medication is classified as an alkylating agent. BCNU, BiCNU Carmustine, BCNU, BiCNU - Chemotherapy Drugs, Chemo Drug Side Effects


Provides information on usage, precautions, side effects and brand names when available. Data provided by various government agencies and health-related organizations. Carmustine: MedlinePlus Drug Information


Learn about the prescription medication BiCNU (Carmustine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. BiCNU (Carmustine) Drug Information: Uses, Side Effects, Drug ...


Carmustine, BCNU Brand names: BiCNUテδづつョGliadelテδづつョ Chemical formula: Drug Forms: Carmustine, BCNU wafers (below) Carmustine Implant Carmustine Carmustine: Definition from Answers.com


All about Carmustine. View complete and up to date Carmustine information - part of the Drugs.com trusted medication database. Carmustine Facts and Comparisons at Drugs.com


Physician reviewed carmustine patient information - includes carmustine description, dosage and directions. carmustine medical facts from Drugs.com


Carmustine (BiCNUテδづつョ) is a chemotherapy drug that is given as a treatment for some types of cancer. It is most commonly used to treat lymphomas, myeloma and brain tumours. This ... Carmustine (BiCNUテδづつョ) - Cancer Information - Macmillan Cancer Support


carmustine /carテδづつキmusテδづつキtine/ (kahr-musテδづつエtテδテつ渡) a cytotoxic alkylating agent of the nitrosourea group, used as an antineoplastic agent. carテδづつキmusテδづつキtine (kテδεつ、r m s-t n) carmustine - definition of carmustine in the Medical dictionary ...


Carmustine should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents. Serious side effects have ... carmustine - Health.com





Featured Reviews

Reviews Progesterone Injection

Progesterone Injection Drug Description PROGESTERONE INJECTION USP IN SESAME OIL FOR INTRAMUSCULAR USE ONLY DRUG DESCRIPTION Progesterone injection, a progestin, is a sterile solution of progesterone in a suitable vegetable oil available...
Read More  |  Review This
Reviews Influenza A H1N1 Monovalent Intranasal Vaccine Live

Influenza A H1N1 Intranasal Vaccine Drug Description Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal DRUG DESCRIPTION Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is a live monovalent vaccine for administration...
Read More  |  Review This
Reviews Tetrabenazine Tablets

Xenazine Drug Description Xenazine® (tetrabenazine) Tablets DEPRESSION AND SUICIDALITY XENAZINE can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington's disease. Anyone...
Read More  |  Review This
Reviews Rifater

Rifater Drug Description RIFATER® (rifampin, isoniazid and pyrazinamide) Tablets WARNING Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk...
Read More  |  Review This
Reviews Wellbutrin XL

Wellbutrin XL Drug Description WELLBUTRIN XL® (bupropion hydrochloride) Extended-Release Tablets WARNING Suicidality and Antidepressant Drugs Use in Treating Psychiatric Disorders: Antidepressants increased the risk compared...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....